Subscribe to Biological Therapies in Psychiatry -  Choose your plan >
IN THIS ISSUE:
April 2009

Medication Treatment for BPD: The Limited Evidence Base
Antipsychotics, especially olanzapine (Zyprexa), may be beneficial in treating borderline personality disorder, but the data are limited and mixed.

Chelation Therapy for Autism?
A study of chelation therapy for autism was stopped due to potential adverse effects.

Varenicline for Smoking Cessation
Varenicline (Chantix) should be used with caution in psychiatric patients attempting to quit smoking.

Minocycline for Schizophrenia: Preliminary Results
The results from an open-label study of minocycline (Solodyn and others) suggest benefit in the treatment of schizophrenia.

In Brief
Modifying risk factors can help prevent dementia; Increased lighting improves cognition in elderly

Medication Treatment for BPD: The Limited Evidence Base

April 2009

Borderline personality disorder (BPD) is characterized by behaviors that can be highly disruptive and costly. It is painful to patients, family members, and associates and causes substantial morbidity and mortality. Psychotherapy is commonly used to treat patients with BPD. For decades, clinicians…

To view the rest of this article, please: